Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Medical Properties Trust, Inc. (MPW) has a Wall Street consensus price target of $5.00, based on estimates from 28 covering analysts. With the stock currently trading at $5.44, this represents a potential downside of -8.1%. The company has a market capitalization of $3.25B.
Analyst price targets range from a low of $5.00 to a high of $5.00, representing a 0% spread in expectations. The median target of $5.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 11 analysts rating the stock as a Buy or Strong Buy,13 rating it Hold, and 4 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, MPW trades at a trailing P/E of -16.5x and forward P/E of 47.6x. Analysts expect EPS to grow +134.6% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how MPW stacks up against sector leader Welltower Inc..
Start ComparisonWall Street's consensus price target for MPW is $5, -8.1% from its current price of $5.44. The below-market target from 28 analysts suggests limited near-term appreciation.
MPW has a consensus rating of "Hold" based on 28 Wall Street analysts. The rating breakdown is mixed, with 13 Hold ratings making up the largest segment. The consensus 12-month price target of $5 implies -8.1% downside from current levels.
At a forward P/E of 47.5941x, MPW trades at a premium valuation. The consensus price target of $5 (-8.1% downside) suggests analysts may view current valuations as stretched.
The most bullish Wall Street analyst has a price target of $5 for MPW, while the most conservative target is $5. The consensus of $5 represents the median expectation. These targets typically reflect 12-month expectations.
MPW is heavily covered by Wall Street, with 28 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 11 have Buy ratings, 13 recommend Hold, and 4 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month MPW stock forecast based on 28 Wall Street analysts shows a consensus price target of $5, with estimates ranging from $5 (bear case) to $5 (bull case). The median consensus rating is "Hold".
MPW trades at a forward P/E ratio of 47.6x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on MPW, with 4 Sell ratings and a price target of $5 (-8.1% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
MPW analyst price targets range from $5 to $5, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $5 consensus represents the middle ground.